informa Brochures
-
ETL: Maximizing Reuse Of Your Clinical Trial Data
5/6/2019
ETL — extract, transform, and load — enables sponsors to operationalize clinical trial data, leverage off the investment they have made in other sources to reuse data, and automate populating key elements for registration on CT.gov and EudraCT.
-
Global Compliance Made Easy
5/6/2019
Global clinical trial disclosure compliance is inherently complex, with over 39 registries, Most sponsors simply lack visibility into all the places they need to disclose information or what their commitments are. Automation can help make global compliance easier.
-
Plain-Language Summaries Best Practices
4/16/2019
Today’s healthcare industry is hyper-focused on patient engagement. With plain-language summaries (PLS), clinical trial sponsors can make patient engagement more than a mantra. In this video, learn PLS best practices from two expert authorities.
-
Real Patient Stories: The Trials Of Finding Clinical Trials Online
2/26/2019
For sponsors, it can be frustrating trying to recruit participants for clinical trials. For patients, trying to find a clinical trial can be equally frustrating. See patients and caregivers reactions when they are shown the easy to understand and navigate website powered by TrialScope Engage.
-
7 Ways To Prepare For The EU Portal
11/27/2018
TrialScope Chief Strategy Officer Thomas Wicks share seven ways sponsors can start preparing for the new EU Portal, starting with participating in beta testing of the portal itself.
-
Ten Big Questions To Ask Your Clinical Transparency Solution Partner
10/3/2018
When considering clinical trial disclosure solutions, it is important to understand the potential partner’s practical experience and how their solution fits your compliance needs today and in the future.
-
TrialScope Disclosure Management Brochure
9/24/2018
TrialScope Clinical Trial Registry Manager (CTRM) delivers the proven solutions clinical trial sponsors need to centralize, track, register, and comply with clinical trial disclosure processes, mitigating compliance risks while giving them greater control over their own clinical trial disclosure reputation.